Chirality of Drugs and Chiral Recognition

[RG #65] Chirality of Drugs and Chiral Recognition

November 1995 - August 1996

Organizer:

Israel Agranat (The Hebrew University of Jerusalem)

The notion of chirality has emerged as a major theme in drug design and discovery. Many of the new chiral drugs are being developed as single enantiomers. Chiral recognition is one of the most significant topics of contemporary stereochemical studies and is an essential component of pharmacological events.

 

Members

men

Israel Agranat

FELLOW
The Hebrew University of Jerusalem
Israel is a professor in the Department of Organic Chemistry at The Hebrew University of Jerusalem.
men

David Avnir

FELLOW
The Hebrew University of Jerusalem
David is a professor in the Department of Organic Chemistry at The Hebrew University of Jerusalem.
men

Robert Glaser

FELLOW
Ben-Gurion University of the Negev
Robert is a professor in the Department of Chemistry at Ben-Gurion of the Negev.
men

Bernard Green

FELLOW
The Hebrew University of Jerusalem
Bernard is a professor in the School of Pharmacy at The Hebrew University of Jerusalem.
men

Ivan Gutman

FELLOW
University of Kragujevac
Ivan is a professor in the Institute of Chemical Sciences at the University of Kragujevac, Yugoslavia.
men

T.P. Radhakrishnan

FELLOW
University of Hyderabad
T.P. is a professor in the School of Chemistry at the University of Hyderabad, India.
men

Volker Schurig

FELLOW
University of Tübingen
Volker is a professor in the Institute of Organic Chemistry at the University of Tübingen, Germany.
men

Gil Shoham

FELLOW
The Hebrew University of Jerusalem
Gil is a professor in the Department of Inorganic Chemistry at The Hebrew University of Jerusalem.
men

Miklos Simonyi

FELLOW
Hungarian Academy of Sciences
Miklos is a professor in the Department of Molecular Pharmacology at the Central Research Institute for Chemistry, Hungarian Academy of Sciences.